Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
WWLP Springfield on MSN1d
Federal Trade Commission finds social and video streaming services pose serious privacy risksA Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
The Biden Administration's emphasis on "antitrust on steroids" and more regulation has harmed the American economy. The next ...
California courts were home to the most federal trade secrets litigation over the past three years, according to a report ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
Social media companies collect, share and process vast troves of information about their users while offering little ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Live news: US Federal Trade Commission accuses top social media platforms of user surveillance on facebook (opens in a new window) Live news: US Federal Trade Commission accuses top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback